Both in Biotechnology
Ocugen vs Lineage Cell Therapeutics
Over the past year OCGN returned −51.6% and LCTX returned −48.5%; their daily moves had a correlation of 0.33.
OCGN −51.6% LCTX −48.5%Growth of $1, one year, split-adjusted
| Metric | OCGN | LCTX |
|---|---|---|
| Price | $0.7452 | $1.01 |
| Market cap | $252.7M | $255.4M |
| Today | +2.83% | 0.00% |
| 1 month | −28.3% | +8.9% |
| 6 months | −50.0% | −30.8% |
| Year to date | −44.8% | −39.5% |
| 1 year | −52.2% | −47.4% |
| Revenue growth (YoY) | +8.4% | −61.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1671.8% | 138.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 19.5× |
| Net cash | $15.9M | $50.8M |
| Dividend yield | — | — |
| Volatility (60d) | 71.1% | 52.4% |
| Short % of float | 33.1% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).